Table 1.
Summary of study characteristics of all included papers.
| Paper | Year | Country | No. of Studies | Age | Measurements | No. of Patients | Treatment Sections |
Type of Subjects | Treatment |
|---|---|---|---|---|---|---|---|---|---|
| Cao FL et al. | 2007 | China | 1 | 14.8 | YDQ, CIAS | 57 | 8 | IA | CBT vs. Control |
| Li G & Dai XY | 2009 | China | 1 | 16.5 | CIAS | 76 | 12 | IA | CBT vs. Control |
| Shao Z et al. | 2015 | China | 1 | 16 | SDS, SCL-90 | 66 | 8 | IA + Depression | CBT + Drug vs. CBT |
| Wei QX | 2008 | China | 1 | 17 | SAS, SDS | 60 | 12 | IA | Others (Psychology Nursing) vs. Control |
| Yang FR et al. | 2005 | China | 1 | 15.2 | IAD-DQ, SCL-90, Time | 52 | 12 | IA | SFBT (No control) |
| Liao XC | 2010 | China | 1 | 15 | IAD-DQ, SCL-90 | 284 | 32 | IA + Depression | CBT + Drug vs. CBT |
| Wu LZ et al. | 2007 | China | 1 | 19.5 | Time | 27 | 6 | IA | Others (HANS) vs. Control |
| Pan SJ et al. | 2010 | China | 1 | 17 | CIAS, SCL-90, SDS | 11 | 16 | IA | Others (EEG Biofeedback) (No control) |
| Liao YR et al. | 2012 | Taiwan | 1 | 14 | CIAS-R, Time | 18 | 8 | IA | Others (Adlerian Group Counseling) vs. Control |
| Li & Dai | 2009 | China | 1 | 16.5 | CIAS | 76 | 9 | IA | CBT vs. Control |
| Bai & Fan | 2007 | China | 1 | 19 | CIAS | 48 | 8 | IA | MLC vs. Control |
| Du YS et al. | 2010 | China | 1 | 15.9 | IOSRS | 56 | 8 | IA | CBT vs. Control |
| Han DH et al. | 2009 | Korea | 1 | 9.3 | YIAS-K, Time | 62 | 8 | IA + ADHD | Drug (Methylphenidate) (No control) |
| Yang R et al. | 2005 | China | 1 | 16 | CIUS, SDS, SCL-90 | 18 | 8 | IA | MLC + Drug (Fluoxetine) + Others (No control) |
| Zhu TM et al. | 2009 | China | 1 | 22.2 | ISS, SAS, SDS, HAMA, HAMD | 45 | 20, 10 | IA | CBT+ acupuncture vs. CBT |
| Yeun YR et al. | 2016 | Korea | 33 | 8~12 | K-scale, YIAS, IGAS | 1330 | 6~22 | IA | CBT, MLC, CBT/MLC + Others, Others |
| Liu J et al. | 2017 | China, Korea | 49 | 15.5~20 | IA | 2304 | IA | CBT, MLC, Others | |
| Winkler et al. | 2013 | China, Korea, US | 16 | 14.8~23 | Anx., Dep., IA, Time | 454 | IA | Drug, CBT, MLC, Others | |
| Liu QX et al. | 2015 | China | 1 | 15.7 | APIUS, Time | 46 | 6 | IA | MLC vs. Control |
| Yang Y et al. | 2017 | China | 1 | 21.1, 21.7 | YIAS | 32 | 10, 20 | IA | CBT vs. Electro-acupuncture |
| Han DH et al. | 2012 | Korea | 1 | 20.2 | YIAS, BDI, Time | 50 | 8 | IA + Depression | Drug (Bupropion) |
| Park JH et al. | 2016 | Korea | 1 | 17 | YIAS, CDI | 86 | 12 | IA + ADHD | Drug (Methylphenidate) vs. Drug (Atomoxetine) |
| Mun SY et al. | 2015 | Korea | 1 | 10.5 | IA, Time | 56 | 8 | IA | CBT vs. Control |
| Lien T.-C. | 2007 | Taiwan | 1 | 16.8 | YDQ | 20 | 8 | IA | MLC vs. Control |
| Huang Z et al. | 2010 | China | 1 | 21 | CGAI | 27 | 6 | IA | MLC vs. Control |
| Khazaei et al. | 2017 | Iran | 1 | 20 | YIAS | 48 | 10 | IA | CBT (Positive psychology Interventions) vs. Control |
| Hui Li et al. | 2017 | China | 1 | 22 | ISS, SCL-90 | 112 | 10 | IA | CBT + Others (EA) vs. CBT vs. Others (EA) |
| Kim SM et al. | 2012 | Korea | 1 | 16 | YIAS, BAI, BDI, Time | 65 | 8 | IA + Depression | CBT + Drug (Bupropion) vs. Drug (Bupropion) |
| Han DH et al. | 2012 | Korea | 1 | 14.2 | YIAS, Time | 15 | 12 | IA | MLC (No control) |
RP: Routine Pharmacotherapy.